**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 13755-38-9 |Sodium nitroferricyanide dihydrate | >99.8 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T
Risk Phrases: 23/24/25
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if
swallowed.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be metabolized to cyanide which in
turn acts by inhibiting cytochrome oxidase impairing cellular
respiration.
Ingestion:
Metabolism may release cyanide, which may result in headache,
dizziness, weakness, collapse, unconsciousness and possible death.
Ingestion may result in symptoms similar to cyanide poisoning which
is characterized by asphyxiation. Large doses of cyanide may result
in suddden loss of consciousness and prompt death; small doses will
prolong the above symptoms 1 to 2 hours.
Inhalation:
May cause respiratory tract irritation. May be metabolized to
cyanide which in turns act by inhibiting cytochrome oxidase
impairing cellular respiration.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Chronic exposure
to cyanide solutions may lead to the development of a "cyanide" rash,
characterized by itching, and by macular, papular, and vesicular
eruptions, and may be accompanied by secondary infections. Exposure
to small amounts of cyanide compounds over long periods of time is
reported to cause loss of appetite, headache, weakness, nausea,
dizziness, and symptoms of irritation of the upper respiratory tract
and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, immediately flush skin with plenty of water.
Remove contaminated clothing and shoes. Get medical aid. Wash
clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Combustion
by-products include oxides of nitrogen and hydrogen cyanide.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Do not breathe dust. Use only with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 13755-38-9:
Belgium - TWA: (listed as iron salts (soluble)): 1 mg/m3 VLE (as
Malaysia: (listed as iron salts (soluble)): 1 mg/m3 TWA (as Fe)
Netherlands: (listed as iron salts (soluble)): 1 mg/m3 MAC (as Fe
Spain: (listed as iron salts (soluble)): 1 mg/m3 VLA-ED (as Fe)
CAS# 14402-89-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: bright red
Odor: practically odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 1.72 g/cm3
Molecular Formula: C5FeN6O.Na2.2H2O
Molecular Weight: 215.8866
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, irritating and toxic fumes and
gases, sodium oxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 13755-38-9: LJ8925000
CAS# 14402-89-2: LJ8750000
LD50/LC50:
Not available.
CAS# 14402-89-2: Oral, mouse: LD50 = 61 mg/kg; Oral, rabbit: LD50 =
34 mg/kg; Oral, rat: LD50 = 99 mg/kg.
Carcinogenicity:
Sodium nitroferricyanide dihydrate -
Not listed by ACGIH, IARC, or NTP.
Sodium nitroferricyanide, anhydrous -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CYANIDES, INORGANIC, SOLID, N.O.S.*
Hazard Class: 6.1
UN Number: 1588
Packing Group: III
IMO
Shipping Name: CYANIDES, INORGANIC, SOLID, N.O.S.
Hazard Class: 6.1
UN Number: 1588
Packing Group: III
RID/ADR
Shipping Name: CYANIDES, INORGANIC, SOLID, N.O.S.
Hazard Class: 6.1
UN Number: 1588
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 38 In case of insufficient ventilation, wear
suitable respiratory equipment.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 13755-38-9: 2
CAS# 14402-89-2: No information available.
Canada
CAS# 14402-89-2 is listed on Canada's DSL List.
CAS# 13755-38-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 14402-89-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13755-38-9 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 14402-89-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 12/16/1997 Revision #7 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Dichlorodimethylsilane, 99%
| 75-78-5 |
|
2-Mesitylenesulfonyl Chloride, 99%
| 773-64-8 |
|
5-Norbornen-2-ol (mixture of endo and exo), 99%
| 13080-90-5 |
|
1,3-Dithiane, 97%
| 505-23-7 |
|
Alpha-D-Cellobiose Octaacetate
| 5346-90-7 |
|
4-Bromobiphenyl, 99%
| 92-66-0 |
|
1,2,3-Heptanetriol
| 103404-57-5 |
|
1-Bromononane, 97%
| 693-58-3 |
|
2-Vinylnaphthalene, 98% Stabilized with 0.4% P-Tert.-Butylcatechol
| 827-54-3 |
|
4-Nitrophenylhydrazine, 10-18% water added, 95%
| 100-16-3 |
|
2-Methyl-1-pentene, 99%
| 763-29-1 |
|
2,5-Dimethylanisole, 99%
| 1706-11-2 |
|
1-Decene, 95%
| 872-05-9 |
|
Methyl s-(-)-lactate, 98%
| 27871-49-4 |
|
3,5-Dibromo-O-Phenylenediamine Mono- Hydrochloride, 99%
| 75568-11-5 |
|
2'-Methylacetophenone, 98%
| 577-16-2 |
|
Ethyl 1-piperidineacetate, 98+%
| 23853-10-3 |
|
1,1,4,4-Tetraphenyl-1,3-Butadiene, Scintillation Grade, 99+%
| 1450-63-1 |
|
3-Chloropropanesulfonyl Chloride, 96%
| 1633-82-5 |
|
Nigrosine, water soluble
| 8005-03-6 |
|
Platinum(ii) iodide, 98.5%
| 7790-39-8 |
|
n-Benzyltropinone, 96% (tlc)
| 28957-72-4 |
|
Acetonylacetone, 97%
| 110-13-4 |
|
(1,4'-Bipiperidine)-4'-carboxamide, 99+%
| 39633-82-4 |
|
Tetraethyleneglycol Monomethyl Ether, 98% (GC)
| 23783-42-8 |
|
Metaldehyde
| 108-62-3 |
|
n-Butyl vinyl ether, 98%
| 111-34-2 |
|
Poly(Alpha-Methylstyrene)
| 25014-31-7 |
|
Copper(II) acetylacetonate, 99%
| 13395-16-9 |
|
Perfluoro(methylcyclohexane), 96%
| 355-02-2 |
|
4-Bromo-2-Fluorophenol, 98%
| 2105-94-4 |
|
2,4-Hexadienoic acid
| 110-44-1 |
|
4-Octyloxyaniline, 98% (Titr.)
| 39905-45-8 |
|
D(+)-galacturonic acid monohydrate, 99%
| 685-73-4 |
|
1,3,3-Trimethoxypropene, 96% (GC), Cis/Trans Mixture: 20/80,
| 17576-35-1 |
|
Sodium Omadine , 40% Aqueous Solution
| 3811-73-2 |
|
Dibenzothiophene sulfone, 97%
| 1016-05-3 |
|
Ethyl 3-Pyridylacetate, 99%
| 39931-77-6 |
|
Iodoacetamide, 98%
| 144-48-9 |
|
Sodium nitroferricyanide dihydrate, reagent ACS, crystals
| 13755-38-9 |
|
1,3-Propane sultone, 99% (gc)
| 1120-71-4 |
|
2-Bromo-4'-methoxyacetophenone, 98%
| 2632-13-5 |
|
2-Thiopheneglyoxylic acid, 97%
| 4075-59-6 |
|
2-Chloro-4-Fluorobenzylcyanide, 99+%
| 75279-56-0 |
|
2-Acetylthiazole, 99%
| 24295-03-2 |
|
2-(Trifluoromethyl)-phenothiazine, 97%
| 92-30-8 |
|
m-Anisic acid, 98%
| 586-38-9 |
|
2-(N-Butylperfluorooctanesulfonamido)ethyl acrylate, stabilized, 77%
| 383-07-3 |
|
3,4-Dichlorobenzaldehyde, 98%
| 6287-38-3 |
|
Silver Vanadate, 98% (Titr.)
| 13497-94-4 |
|
|